• Konstantinos Tsamakis, Maria Gavriatopoulou, Dimitrios Schizas, Athina Stravodimou, Aikaterini Mougkou, Dimitrios Tsiptsios, Vasileios Sioulas, Eleftherios Spartalis, Athanasios D Sioulas, Charalampos Tsamakis, Nikolaos Charalampakis, Christoph Mueller, Donna Arya, Paul Zarogoulidis, Demetrios A Spandidos, Meletios A Dimopoulos, Charalabos Papageorgiou, and Emmanouil Rizos.
• Second Department of Psychiatry, University of Athens, 'ATTIKON' University Hospital, 12462 Athens, Greece.
• Oncol Lett. 2020 Jul 1; 20 (1): 441-447.

AbstractCOVID-19 has caused unprecedented societal turmoil, triggering a rapid, still ongoing, transformation of healthcare provision on a global level. In this new landscape, it is highly important to acknowledge the challenges this pandemic poses on the care of the particularly vulnerable cancer patients and the subsequent psychosocial impact on them. We have outlined our clinical experience in managing patients with gastrointestinal, hematological, gynaecological, dermatological, neurological, thyroid, lung and paediatric cancers in the COVID-19 era and have reviewed the emerging literature around barriers to care of oncology patients and how this crisis affects them. Moreover, evolving treatment strategies and novel ways of addressing the needs of oncology patients in the new context of the pandemic are discussed.Copyright: © Tsamakis et al.

10 keywords...

hide…